• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Latest developments and challenges in the diagnosis of human West Nile virus infection
 
  • Details
  • Full
Options
2015
Journal Article
Title

Latest developments and challenges in the diagnosis of human West Nile virus infection

Abstract
West Nile virus (WNV) is a mosquito-borne flavivirus responsible for an increasing number of human outbreaks of neuroinvasive disease in Europe and in North America. Notwithstanding the improvements in the knowledge of virus epidemiology and clinical course of infection and the development of new laboratory tests, the diagnosis of WNV infection remains challenging and many cases still remain unrecognized. WNV genome diversity, transient viremia with low viral load and cross-reactivity with other flaviviruses of the antibodies induced by WNV infection are important hurdles that require the diagnosis to be performed by experienced laboratories. Herein, we present and discuss the novel findings on the molecular epidemiology and clinical features of WNV infection in humans with special focus on Europe, the performance of diagnostic tests and the novel methods that have been developed for the diagnosis of WNV infection. A view on how the field might evolve in the future is also presented.
Author(s)
Barzon, Luisa
University of Padova
Pacenti, Monia
Padua University Hospital
Ulbert, Sebastian  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Palù, Giorgio
University of Padova
Journal
Expert review of anti-infective therapy  
DOI
10.1586/14787210.2015.1007044
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Keyword(s)
  • West Nile Virus

  • test performance

  • blood

  • diagnosis

  • molecular test

  • neutralization test

  • serology test

  • serum

  • urine

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024